This funding opportunity supports the translation and validation of in vivo imaging systems and related technologies such as data science and spectroscopy. It aims to develop methods and tools that address fundamental cancer biology, risk, diagnosis, treatment, and disease status. The grant encourages collaborations between academic and industrial partners to accelerate clinical and diagnostic advances.
Eligible applicants include a wide range of organizations such as governments, nonprofits, small businesses, academic institutions, tribal organizations, and others including foreign entities and regional organizations.
